片受体对抗性和神经对金钱奖励的反应:在轻度和重度酒精使用者的试点研究
Joshua L Gowin1, Matthew E Sloan2,3,4,5,6,7, Katelyn T Kirk-Provencher1
1Department of Radiology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Journal of psychopharmacology (Oxford, England)
|August 2, 2023
概括
像纳尔特雷克松这样的阿片类抗体在轻度或重度的酒精使用者中不会显著改变大脑对货币暗示的奖励反应. 这些发现表明,酒精使用障碍药物治疗对神经奖励通路的影响有限.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 成研究 研究成研究
背景情况:
- 酒精使用障碍 (AUD) 是一个重要的公共卫生问题,死亡率高.
- 阿片类受体对抗剂 (纳尔特雷,纳尔梅芬) 是已批准的AUD药物疗法.
- 它们的机制,特别是对神经奖励处理的影响,需要进一步对人类进行表征.
研究的目的:
- 调查阿片类药物对抗对神经对金钱奖励反应的影响.
- 为了比较轻度和重度酒精使用者的这些影响.
主要方法:
- 两个双盲,随机,交叉试点研究.
- 具有货币激励延迟任务的功能性MRI (fMRI).
- 在11名轻度和9名重度酒精使用者中,阿片类药物抗剂与安慰剂的急性管理.
主要成果:
- 观察到一个显著的神经奖励反应 (BOLD激活在核 accumbens) 货币线索.
- 与安慰剂相比,阿片类药物对抗在两组饮酒者中都对这种奖励激活产生了小而无意义的影响.
结论:
- 片对抗剂药物并没有显著减少神经激活到核中金钱奖励的作用.
- 目前的证据表明,这些药物可能不会调节患有AUD的个体在核 accumbens中的奖励处理.
相关概念视频
Opioid Receptors: Overview
1.0K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
1.0K
Analgesia and Pain Management
660
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
660
Drug Abuse and Addiction: Pharmacological Phenomena
521
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
521
CNS Depressants: Alcohol and Nicotine
244
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
244
Opioid Analgesics: Synthetic and Semisynthetic Opioids
336
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
336
Drug-Receptor Interaction: Agonist
2.5K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
2.5K


